Spring Allergy Capitals 2015 - Asthma and Allergy Foundation of ...

3 downloads 214 Views 131KB Size Report
2015 Rank - Rankings for the Allergy Capitals™ are based on analysis of data from factors including: Prevalence Data,
"The Most Challenging Places to Live with Spring Allergies"   

Worse than Average Average Better than Average

2015 Spring Rank

Overall

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

                                   

www.AllergyCapitals.com

Asthma and Allergy Foundation of America

www.AllergyCapitals.com © 2015 Asthma and Allergy Foundation of America (Factors are not weighted equally)

Rank Last Year

5 1 4 2 16 10 12 11 17 8 21 19 3 6 18 14 9 15 7 27 46 30 25 n/r 20 49 31 75 66 34 47 37 24 42 52 26

Metropolitan Area

Jackson, MS Louisville, KY Oklahoma City, OK Memphis, TN Knoxville, TN McAllen, TX Wichita, KS Dayton, OH Providence, RI Richmond, VA Little Rock, AR Tulsa, OK Baton Rouge, LA Chattanooga, TN New Orleans, LA Columbia, SC Birmingham, AL San Antonio, TX Dallas, TX Syracuse, NY Greenville, SC Charleston, SC Nashville, TN Winston-Salem, NC St. Louis, MO Springfield, MA Augusta, GA Miami, FL Virginia Beach, VA Jacksonville, FL Charlotte, NC Toledo, OH Greensboro, NC Madison, WI Tucson, AZ Buffalo, NY

Total Score (Avg. 67.02)

100.00 98.34 95.64 94.64 94.51 89.56 86.43 86.15 86.06 85.79 85.48 84.59 84.30 83.91 82.04 81.25 80.29 79.17 79.00 78.97 78.04 77.65 76.75 75.15 74.99 74.39 73.76 73.63 73.27 73.15 72.75 72.65 71.86 71.84 71.64 71.22

Subtotal: Subtotal: Medicine Pollen Score* Utilization per (Avg. 300 Patient (Avg. 1.15 grains/cubic meter Medications Per air daily) Est. Patient)

                                   

                                   

Subtotal: Board Certified Allergists per Patient (Avg. 0.91 Board Certified Allergists Per 10,000 Est. Patients)

                                   

This report is made possible by a sponsorship grant from Dymista® and MEDA Pharmaceuticals

Page 1 www.AllergyCapitals.com

2015 Spring Allergy Capitals™

2015 Spring Rank

Overall

37 38

                                                 

39

40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86

www.AllergyCapitals.com

Asthma and Allergy Foundation of America

Rank Last Year

55 22 29 57 13 85 51 71 62 36 39 32 28 33 44 50 69 68 43 35 41 54 48 23 60 58 80 40 59 56 61 83 63 70 82 74 89 65 73 53 93 79 38 96 81 67 92 64 n/r 86

Metropolitan Area

Omaha, NE Philadelphia, PA New Haven, CT Des Moines, IA New York, NY Cape Coral, FL El Paso, TX Albuquerque, NM Las Vegas, NV Grand Rapids, MI Hartford, CT Akron, OH Houston, TX Detroit, MI Albany, NY Austin, TX Kansas City, MO Rochester, NY Bridgeport, CT Youngstown, OH Pittsburgh, PA Fresno, CA Allentown, PA Columbus, OH Atlanta, GA Scranton, PA Indianapolis, IN Cleveland, OH Tampa, FL Phoenix, AZ Cincinnati, OH Orlando, FL Lakeland, FL Harrisburg, PA Riverside, CA Milwaukee, WI Worcester, MA Minneapolis, MN Baltimore, MD Chicago, IL Salt Lake City, UT Boston, MA Los Angeles, CA Ogden, UT Bakersfield, CA Washington, DC Seattle, WA Raleigh, NC Abilene, TX Sarasota, FL

Total Score (Avg. 67.02)

70.98 70.77 70.43 69.92 69.27 68.60 68.54 67.71 67.69 67.64 67.38 66.73 66.62 66.45 66.29 65.71 65.56 65.38 65.38 65.17 64.84 63.95 63.79 63.22 62.72 62.16 61.95 61.87 61.66 61.34 59.82 59.63 59.59 59.40 59.23 57.93 57.64 57.61 56.84 56.25 55.55 55.12 54.78 54.30 54.11 53.86 53.42 51.80 51.59 50.75

Subtotal: Subtotal: Medicine Pollen Score* Utilization per (Avg. 300 Patient (Avg. 1.15 grains/cubic meter Medications Per air daily) Est. Patient)

                                                 

                                                 

Subtotal: Board Certified Allergists per Patient (Avg. 0.91 Board Certified Allergists Per 10,000 Est. Patients)

                                                 

This report is made possible by a sponsorship grant from Dymista® and MEDA Pharmaceuticals

Page 2 www.AllergyCapitals.com

2015 Spring Allergy Capitals™

2015 Spring Rank

Overall

87 88 89 90 91 92 93 94 95 96 97 98 99 100

             

Rank Last Year

95 87 84 78 n/r 77 94 98 91 88 n/r 100 99 97

Metropolitan Area

Boise, ID Palm Bay, FL Stockton, CA San Jose, CA Spokane, WA San Francisco, CA Portland, OR Denver, CO Oxnard, CA Sacramento, CA Provo, UT Colorado Springs, CO Daytona Beach, FL San Diego, CA

Total Score (Avg. 67.02)

50.64 50.64 50.44 50.17 50.05 49.98 49.37 49.37 49.33 48.76 48.63 47.38 47.25 42.60

Subtotal: Subtotal: Medicine Pollen Score* Utilization per (Avg. 300 Patient (Avg. 1.15 grains/cubic meter Medications Per air daily) Est. Patient)

             

Subtotal: Board Certified Allergists per Patient (Avg. 0.91 Board Certified Allergists Per 10,000 Est. Patients)

             

             

2015 Rank - Rankings for the Allergy Capitals™ are based on analysis of data from factors including: Prevalence Data, Seasonal Pollen, Allergy Medicine Utilization per Patient, and the number of Board Certified Allergists per patient. Weights were applied to each factor and a composite final score was calculated for each Metropolitan Statistical Area (MSA). Total Score - Final total scores and subtotals were rescaled assigning 100 points to the largest score and presenting all other scores as a percentage of the largest. The metro area with a total score of 100 points did not necessarily have the “most severe" score for all factors, but, rather, the highest total weighted final score overall. Pollen Score* - Quantitative data analysis of average recorded pollen/mold spore levels and predicted prevalence for certain types of pollens/molds over the most recent spring season and the duration of the peak season for the most allergenic pollen types; this score also takes into consideration local prevalence statistics for people affected by allergies to pollen. (Regarding daily pollen counts: previous studies have shown that daily pollen concentrations of 150+ grains per cubic meter of airborne allergenic pollen is a sufficiently high concentration which can trigger allergy symptoms in a large percentage of the allergic population.) Medicine Utilization per Patient Score - Quantitative data analysis of recorded per capita utilization of recorded pharmacy data for prescription (RX) allergy medicines in each metro area during the most recent spring season. Also includes over-the-counter (OTC) and behind-the-counter (BTC) allergy medication sales at the pharmacy counter. Board Certified Allergists per Patient Score - Quantitative data analysis for the most recent spring season of the number of Board Certified allergy and immunology specialists per 10,000 estimated patients. GOVERNMENTAL SOURCES: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Allergic Rhinitis Information (2014) U.S. Department of Commerce, Bureau of the Census, U.S. Census 2000, 2013 Updates U.S. Department of Commerce, National Oceanic and Atmospheric Administration, Air Resources Laboratory (ARL), Air Stagnation Climatology for the U.S. (2014) U.S. Environmental Protection Agency, Status and Trends, Latest Findings on National Air Quality (2014) NON-GOVERNMENTAL SOURCES: Asthma and Allergy Foundation of America, "Asthma and Allergy Answers" (2015) American Board of Medical Specialties, Specialist Database (2014) INDUSTRY SOURCES: IMS/SDI Pollen.com Database (2014) IMS Medication Database (2014)

© AAFA is solely responsible for the contents of this report. AAFA, Founded in 1953, is the leading national advocacy organization for the allergy community in the U.S. AAFA provides education, promotes advocacy and funds research.

www.AllergyCapitals.com Asthma and Allergy Foundation of America

This report is made possible by a sponsorship grant from Dymista® and MEDA Pharmaceuticals Page 3 www.AllergyCapitals.com

2015 Spring Allergy Capitals™